Search

Eurofins Scientific SE

Abrir

72.74 4.09

Visão Geral

Variação de preço das ações

24h

Atual

Mín

69.6

Máximo

73.26

Indicadores-chave

By Trading Economics

Rendimento

123M

Vendas

1.8B

P/E

Médio do Setor

29.577

21.746

EPS

1.16

Rendimento de Dividendos

0.97

Margem de lucro

6.827

Funcionários

65,000

EBITDA

409M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+1.52% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.97%

4.48%

Próximos Ganhos

25 de fev. de 2026

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

12B

Abertura anterior

68.65

Fecho anterior

72.74

Pontuação Técnica

By Trading Central

Confiança

Weak Bearish Evidence

Eurofins Scientific SE Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

12 de jan. de 2026, 23:54 UTC

Conversa de Mercado

CBA Could Underperform Again in 2026 -- Market Talk

12 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

12 de jan. de 2026, 23:48 UTC

Conversa de Mercado

Nikkei May Rise on Weaker Yen -- Market Talk

12 de jan. de 2026, 23:43 UTC

Conversa de Mercado

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 de jan. de 2026, 23:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 de jan. de 2026, 21:56 UTC

Conversa de Mercado

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Basic Materials Roundup: Market Talk

12 de jan. de 2026, 21:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

12 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Ganhos

Auto & Transport Roundup: Market Talk

12 de jan. de 2026, 21:18 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

12 de jan. de 2026, 21:18 UTC

Conversa de Mercado

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 de jan. de 2026, 20:54 UTC

Ganhos

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 de jan. de 2026, 20:48 UTC

Conversa de Mercado

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 de jan. de 2026, 20:33 UTC

Conversa de Mercado

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 de jan. de 2026, 20:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 de jan. de 2026, 20:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 de jan. de 2026, 19:39 UTC

Conversa de Mercado

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 de jan. de 2026, 19:36 UTC

Conversa de Mercado

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 de jan. de 2026, 19:36 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

12 de jan. de 2026, 19:33 UTC

Conversa de Mercado

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 de jan. de 2026, 19:24 UTC

Aquisições, Fusões, Aquisições de Empresas

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 de jan. de 2026, 19:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 de jan. de 2026, 18:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 de jan. de 2026, 18:20 UTC

Aquisições, Fusões, Aquisições de Empresas

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 de jan. de 2026, 18:19 UTC

Conversa de Mercado

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 de jan. de 2026, 18:16 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 de jan. de 2026, 18:09 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

12 de jan. de 2026, 18:09 UTC

Conversa de Mercado

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 de jan. de 2026, 18:01 UTC

Aquisições, Fusões, Aquisições de Empresas

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 de jan. de 2026, 18:00 UTC

Conversa de Mercado

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Eurofins Scientific SE Previsão

Preço-alvo

By TipRanks

1.52% parte superior

Previsão para 12 meses

Média 70.33 EUR  1.52%

Máximo 75 EUR

Mínimo 64 EUR

Com base em 3 analistas de Wall Street que oferecem metas de preço de 12 meses para Eurofins Scientific SE - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

3 ratings

2

Comprar

1

Manter

0

Vender

Pontuação Técnica

By Trading Central

54.22 / 56.82Suporte e Resistência

Curto Prazo

Weak Bearish Evidence

Médio Prazo

Strong Bullish Evidence

Longo Prazo

Bullish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Eurofins Scientific SE

Eurofins Scientific SE, together with its subsidiaries, provides various analytical testing and laboratory services worldwide. The company offers a portfolio of various analytical methods and tests to evaluate the safety, identity, composition, authenticity, origin, traceability, and purity of various products. It provides services such as agroscience, including biological assessment, consumer and human, and environmental safety, product chemistry, regulatory consultancy, and seed services; agro testing; assurance, such as product inspection, auditing, certification, training and consultation of food, consumer products, healthcare and cosmetics, and food supplements; biopharma, and clinical diagnostics. In addition, the company offers consumer product testing, which include sustainability, expert services and regulatory, consumer research and sensory evaluation, audits, testing, certifications and approvals, inspections, and training courses for various industries; cosmetics and personal care; environment testing, including water, air, soil, waste, and other products testing; and food and feed testing that include allergen, GMO, grain, meat, nano material, pesticides, and residual DNA testing. Further, it offers audit and certification, training and consulting; food irradiation and labelling, heavy metals, carbohydrates, radioactivity, nutritional analysis, microbiolody, and testing for persistent organic pollutants, veterinary drug residue, dioxins and organic contaminants, pesticides, mycotoxins, and vitamins, as well as analyses for genetic modifications. Additionally, the company provides forensic, genomic, maritime, materials and engineering, REACH, and other services. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg.
help-icon Live chat